A potent immunosuppressive activity was found in the culture broth of the fungus Isaria sinclairii (ATCC 24400). The metabolite, ISP-I ((2JS,3^,4^)-(j&)-2-amino-3,4-dihydroxy-2-hydroxymethyl-14-oxoeicos-6-enoic acid, myriocin = thermozymocidin) suppressed the proliferation of lymphocytes in mouse allogeneic mixed lymphocyte reaction, but had no effect on the growth of humantumor cell lines. It also suppressed the appearance of plaque-forming cells in response to sheep red blood cells and the generation of allo-reactive cytotoxic T lymphocytes in mice after intraperitoneal or oral administration.
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Chinese traditional medicine as a drug for eternal youth1 1*. In this paper we describe the isolation, structure elucidation and some chemical and biological properties of an immunosuppressive metabolite ( Fig. 1) , produced by /. sinclairii.
Materials and Methods Fermentation of Isaria and Trichoderma Species for Screening
The microorganismsand the media used are listed in Tables 1 and 2 . Trichoderma species were provided by the Tottori Mycological Institute. Erlenmeyer flasks (500-ml) containing 100ml of the medium was sterilized at 121°C for 20 minutes. A portion of slant culture of each strain was inoculated into the medium and cultured at 30°C for 10 days on a reciprocal shaker (145 strokes/minute).
Fractionation of the Culture Broths Each culture broth was filtered and the mycelial cake was extracted with MeOH(50mi x 2, Fr. 1). The filtrate was passed through an Amberlite XAD-2column (2 i.d. x 15cm) eluting with water 200ml (Fr. 2), MeOH200 ml (Fr. 3) and acetone 200 ml (Fr. 4) . Each fraction was concentrated to dryness in vacuo.
Fermentation of Isaria sinclairii (ATCC24400)
The seed mediumand a production mediumwere of the same composition as the screening medium (Table 2 ). An Erlenmeyer flask (500-ml) containing 100ml of the seed medium was sterilized at 121°C for 20 minutes. A portion of slant culture of /. Sinclairii Immunosuppressive activity was evaluated by mousê allogeneic mixed lymphocyte reaction as described in Materials and Methods.
' -;^50%i nhi bi t i on at 10/ i g/ ml . +; >50%i nhi bition at lOjUg/ml,^50% inhibition at 1fig/ml ++; >50% inhibition at 10^g/ml, 50-80% inhibition at ljug/ml. +++; >80% inhibition at 10/ig/ml, 80%
inhibition at 1 /ig/ml.
(ATCC24400) was inoculated into the medium and cultured at 30°C for 7 days on a reciprocal shaker (145 strokes/minute). The resultant culture was transferred to the same medium (5 liters) in a 10-liter jar fermentor which had been sterilized at 121°G for 30 minutes. The mixture was cultured at 30°C for 10 days with agitation at 150rpm and with an air flow of 5 liters per minute.
Fermentation of Myriococcum albomyces (ATCC 16425) and Isolation of Myriocin
A seed medium (100 ml) containing glucose 3%, yeast extract (Difco) 0.5%, K2HPO4 0.03% and MgSO4-7H2O0.05% at pH 5.5 was poured into a 500-ml Erlenmeyer flask and sterilized at 121°C
for 20minutes. A portion of slant culture of M. 3.5 FEB. 1994 albomyces (ATCC16425) was inoculated into the medium and cultured at 40°C for 4 days on a reciprocal shaker (145 strokes/minute). The resultant culture was transferred to the same medium (5 liters) in a 10-liter jar fermentor which had been sterilized at 121°C for 30 minutes. The mixture was cultured at 40°C for 10 days with an agitation at 150rpmand with an air flow of 5 liters per minute. The culture broth was filtered and the mycelial cake was extracted with MeOH(500mi x 3). The MeOHextract from the mycelium and the nitrate (4.5 liters) were combined and applied to a column of Amberlite XAD-2 (4.5 i.d. x 75 cm). The column was washed with water (4 liters) and 50% aqueous MeOH (2 liters), then eluted with 80% aqueous MeOH(4 liters). The eluate was evaporated under reduced pressure to give crude myriocin. Recrystallization from MeOHgave pure myriocin (645 mg).
Fermentation of Mycelia sterilia (ATCC20349) and Isolation of Thermozymocidin M. sterilia (ATCC20349) was cultured in the same manner as M. albomyces. Thermozymocidin (800mg) was obtained from the culture broth in the same way as described above for myriocin.
Drugs
CsA (Sandimmun) was purchased from Sandoz Co., Ltd. Animals Male BALB/c (H-2d) and C57BL/6 (H-2b) mice were purchased from Japan Charles River
Laboratories, Kanagawa, Japan. All animals were used at 6 to 10 weeks of age.
Cell Culture Medium RPMI 1640 (Nissui Seiyaku, Tokyo, Japan) was supplemented with 2 mML-glutamine, kanamycin at 60/ig/ml, penicillin at lOOu/ml, lOniM HEPESand 0.1% NaHCO3. Fetal calf serum (FCS, Hyclone, Laboratories Inc., Logan, Utah) was heat-inactivated at 56°C for 30 minutes and added to the medium BALB/cmice were immunized intravenously with 107 sheep red blood cells (SRBC) and a test substance was administered intraperitoneally for 4 consecutive days thereafter. Four days after immunization, a single cell suspension of spleen cells was prepared from each mouse and used for the assay of direct plaqueforming cells (PFC) in the presence of SRBC and guinea-pig complement.
Generation of Allo-reactive Cytotoxic T Lymphocytes (CTL)14) in Mice BALB/c mice (H-2d) were immunized intraperitoneally with 107 cells of EL4 mouse leukemia cell line derived from C57BL/6 mice (H-2b). The test substance was administered intraperitoneally or orally for 5 consecutive days thereafter. Ten days after the immunization, a single cell suspension of spleen cells from each mouse was prepared and used as effector cells for CTLassay. In vitro-gvown EL4cells were prelabeled with Na251CrO4 (370 KBq) for 1 hour at 37°C and used as target cells. The radiolabeled EL4 cells (5 x 103) were incubated with various numbers of effector cells in a 96-well flat-bottomed microtest plate for 4 hours at 37°C. The radioactivity released from lysed target cells was determined as lytic unit (LU)15) per spleen. OneLUis defined as the number ofeffector cells required to cause 25%lysis of5 x 103 target cells. 
Results
Screening for Immunosuppressive Activity Table 1 showedthe results of screening of five strains of Isaria and six strains of Trichoderma. Strong immunosuppressive activity was found in Fr. 3 of /. sinclairii and T. polysporum. As Fr. 3 of /. sinclairii showed the strongest activity, we purified the active substance from the culture broth of this fungus.
Isolation of Immunosuppressant
An immunosuppressant was isolated from the culture broth of /. sinclairii (ATCC24400) through bioassay-directed fractionation as shown in Fig. 2 . The activity was followed by meansof the mouse allogeneic mixed lymphocyte reaction (MLR). The filtered broth (4.5 liters) was applied to an Amberlite XAD-2 column (4.5 i.d. x 75 cm) eluting with water (4 liters), MeOH(4 liters) and acetone (4 liters). The activity was found in the MeOHfraction, which was concentrated by evaporation and partitioned between (parenthesis : relative activity) 212 THE JOURNAL OF ANTIBIOTICS FEB. 1994 water and EtOAc. Strong activity was found in the aqueous layer, which was extracted with «-BuOH. The organic layer, showing potent activity, was evaporated and the residue was purified by thin layer chromatography [Kieselgel 60F, Merck, 0.5 mm, v/v) 20-H3) . These data coincide with those of myriocin17'18) (thermozymocidin)19), which is an antifungal agent isolated from M. albomyces (M. sterilia).
The absolute structure of myriocin (thermozymocidin) was determined by X-ray analysis20) and asymmetric synthesis2lf22). Table 3 shows the melting points and optical rotations of these three compounds. These data and the NMRspectral data indicate that the absolute structure ofISP-I is identical with that ofmyriocin.
Biological Properties of Myriocin Effect of Myriocin on Mouse Allogeneic MLR
The effect of myriocin on mouse allogeneic MLR was examined in comparison with that of CsA. Table 4 shows the IC50 values of myriocin and CsAon mouse allogeneic MLR.These results indicate that myriocin is 5-to 10-fold more potent than CsA in its inhibition of lymphocyte proliferation in mouse allogeneic MLR.
Effect of Myriocin on Growth of HumanLeukemia Cell Lines In Vitro
The effect of myriocin on growth of humanleukemia cell lines was examined. As shown in Table 5 , 10/ig/ml of myriocin had no growth-inhibitory activity, whereas the IC50 values of CsA were below 10/jg/ml for 3 leukemia cell lines. The anti-proliferative activity of myriocin, like that of CsA, is highly specific for antigen-stimulated lymphocytes, and is not due to nonspecific growth-inhibitory activity.
Effect of Myriocin on T Cell-dependent Antibody Production In Vivo
The influence of myriocin on T cell-dependent antibody production was examined by using SRBCas an antigen. After the immunization of 107 SRBCinto BALB/cmice, myriocin and CsA were administered intraperitoneally from day 0 to 3. On day 4, spleen cells of each mouse were recovered and PFCs were determined. As shown in Table 6 , intraperitoneal administration of myriocin led to a dose-dependent decrease of the PFCresponse and myriocin showed 10-fold greater potency than CsA for inhibiting T Table 6 . Effect ofmyriocin and cyclosporin A (CsA) on cell-dependent antibody production.
Effect of Myriocin on Generation of Alloreactive Cytotoxic T Lymphocytes (CTL) In Vivo
The effect of myriocin on allo-reactive CTL induction was examined. BALB/cmice (H-2d) were immunized with 1 07 EL4 leukemia cells derived from C57BL/6 mice (H-2b). Myriocin and CsA were administered from day 0 to 4. On day 10, spleen cells from each mousewere recovered and alloreactive (H-2b restricted) CTLactivities in the spleen cells were determined by using 51Cr-labeled EL4
T cell-dependent antibody production in vivo. FEB. 1994 target cells (H-2b).
As shown in Table 7 , myriocin suppressed allo-reactive CTL generation in a dose-dependent manner. The minimumeffective concentrations of myriocin and CsAwere estimated to be 0.1 mg/kg and lO mg/kg, respectively. Thus, myriocin is 100-fold more potent than CsA in its inhibition of allo-reactive CTL generation in alloantigen-immunized mice.
Discussion
A screening study of fungi of Isaria and Trichoderma species for immunosuppressive activity on mouse allogeneic MLRrevealed that culture broth of Isaria sinclairii (ATCC24400), the imperfect stage of Cordyceps sinclairii, contained potent activity. Fractionation guided by bioassay led to the isolation of the active principle, ISP-I, which was identified as (2S,3i?,47?)-(£)-2-amino-3,4-dihydroxy-2-hydroxymethyl-14-oxoeicos-6-enoic acid. This structure is identical with myriocin1 7'1 8) or thermozymocidin19), previously isolated as an antifungal agent. Nevertheless, we have found for the first time that myriocin is a potent immunosuppressant, being 10-fold more potent than CsA in terms of its inhibition of lymphocyte proliferation in mouse allogeneic MLR. The anti-proliferative activity of myriocin is specific for antigen-stimulated lymphocytes, and is not due to nonspecific growth-inhibitory activity, since myriocin had no effect on the growth of several human leukemia cell lines in vitro. Myriocin also suppressed allo-reactive CTLgeneration and T cell-dependent antibody production with a potency 10-to 100-fold greater than that of CsAin vivo.
In other experiments, we also found that myriocin inhibited interleukin 2 (IL-2)-induced T cell proliferation, but not IL-2 production from alloantigen-stimulated T cells (unpublished data). Since CsA and FK-506 were reported2'23) to inhibit IL-2 production from antigen-or mitogen-stimulated helper T cells, the mechanismof immunosuppressive action of myriocin appears to be different from that of CsA and FK-506. Myriocin is an unusual lipophilic amino acid, whose biosynthetic pathway24) may be similar to that of sphingosine. It is structurally quite different from the cyclic polypeptide CsAor the macrolide FK-506, has a smaller molecular weight.
The studies described in this paper suggest that myriocin is a powerful immunosuppressant with a novel mechanism. Thus, myriocin or its derivatives mayhave clinical potential for organ transplantation and for the treatment of autoimmunediseases. The structure-activity relationships of myriocin derivatives are described in the succeeding paper.
